Published in Immunotherapy Weekly, October 11th, 2006
"This study examined the ability of E2F decoy oligodeoxynucleotides to inhibit proliferation of synovial fibroblasts derived from patients with rheumatoid arthritis (RA). The effect of E2F decoy ODN on cartilage invasion by RA synovium in a murine model of human RA was also investigated," scientists writing in the International Journal of Molecular Medicine reported.
"E2F decoy ODN were introduced into synovial tissue and synovial fibroblasts derived...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly